Skip to main content

Malecek Michael J's Form 4 filing

Prothena Corp Public Ltd Co (PRTA) · filed Dec 2, 2022

Accession no.
0001140361-22-044321
Filed
Dec 2, 2022
Trade date
Nov 30, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 8 non-derivative transactions and 1 derivative transaction. Open-market sales total $311.4K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Malecek Michael JCIK 0001779336Officer (Chief Legal Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 30, 2022Ordinary Shares, par value $0.01 per shareMOption exerciseAcquired+5,000$10.27+$51,3505,000Direct
Nov 30, 2022Ordinary Shares, par value $0.01 per shareSSaleDisposed−142$59.92F2−$8,508.644,858Direct
Nov 30, 2022Ordinary Shares, par value $0.01 per shareSSaleDisposed−1,696$60.96F3−$103,388.163,162Direct
Nov 30, 2022Ordinary Shares, par value $0.01 per shareSSaleDisposed−1,625$62.06F4−$100,847.51,537Direct
Nov 30, 2022Ordinary Shares, par value $0.01 per shareSSaleDisposed−456$62.85F5−$28,659.61,081Direct
Nov 30, 2022Ordinary Shares, par value $0.01 per shareSSaleDisposed−494$64.13F6−$31,680.22587Direct
Nov 30, 2022Ordinary Shares, par value $0.01 per shareSSaleDisposed−411$64.96F7−$26,698.56176Direct
Nov 30, 2022Ordinary Shares, par value $0.01 per shareSSaleDisposed−176$65.87F8−$11,593.120Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 30, 2022Ordinary SharesMOption exerciseDisposed−5,000$0.00$0140,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The transaction was executed in multiple trades in prices ranging from $59.32 to $60.01, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnotes 2 through 8 of this Form 4.

Referenced by the price of 1 transaction in Table I.

F3

The transaction was executed in multiple trades in prices ranging from $60.565 to $61.50, inclusive.

Referenced by the price of 1 transaction in Table I.

F4

The transaction was executed in multiple trades in prices ranging from $61.57 to $62.56, inclusive.

Referenced by the price of 1 transaction in Table I.

F5

The transaction was executed in multiple trades in prices ranging from $62.575 to $63.295, inclusive.

Referenced by the price of 1 transaction in Table I.

F6

The transaction was executed in multiple trades in prices ranging from $63.82 to $64.815, inclusive.

Referenced by the price of 1 transaction in Table I.

F7

The transaction was executed in multiple trades in prices ranging from $64.82 to $65.725, inclusive.

Referenced by the price of 1 transaction in Table I.

F8

The transaction was executed in multiple trades in prices ranging from $65.82 to $65.94, inclusive.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)